JP Morgan conference

Estrigenix Therapeutics, Inc. to Attend JP Morgan Meeting

MILWAUKEE (Dec. 14, 2022) – Estrigenix Therapeutics, Inc., a Wisconsin-based, privately held pharmaceutical company leading the way in estrogen biology, is announcing William Donaldson, Ph.D, chief executive officer (CEO) and Patricia Scheller, executive chairwoman, will attend the JP Morgan conference in San Francisco January 9 – 12, 2023. Estrigenix was formed in 2018 to develop <strong>Estrigenix Therapeutics, Inc. to Attend JP Morgan Meeting</strong>